Objective: Navigated transcranial magnetic stimulation (nTMS) has seldom been used to study visuospatial (VS) circuits so far. Our work studied (I) VS functions in neurosurgical oncological patients by using repetitive nTMS (rnTMS), (II) the possible subcortical circuits underneath, and (III) the correspondence between nTMS and direct cortical stimulation (DCS) during awake procedures. Methods: We designed a monocentric prospective study, adopting a protocol to use rnTMS for preoperative planning, including VS functions for lesions potentially involving the VS network, including neurosurgical awake and asleep procedures. nTMS-based-DTI tractography allowed the visualization of subcortical circuits. Statistical analyses on nTMS/DCS points were performed. Clinical results were collected pre- and postoperatively. Results: Finally, 27 patients with primitive intra-axial brain lesions were enrolled between April 2023 and March 2024. Specific tests and an experimental integrated VS test (VISA) were used. The clinical evaluation (at 5 ± 7, 30 ± 10, 90 ± 10 days after surgery) documented 33% of patients with neglect in the left hemisphere four days after surgery and, during the 3-month follow-up, preservation of visuospatial function/clinical recovery (90.62% in MMSE, 98.86% in the bell test, 80% in the clock test, and 98% in the OCS test). The surgical strategy was modulated according to the nTMS map. Subcortical bundles were traced to identify those most involved in these functions: SFLII > SLFII > SLFI. A comparison of the nTMS and DCS points in awake surgery (n = 10 patients) documented a sensitivity (Se) of 12%, a specificity (Sp) of 91.21%, a positive predictive value (PPV) of 42%, a negative predictive value (NPV) of 66%, and an accuracy of ~63.7%. Conclusions: Based on our preliminary results, nTMS is advantageous for studying cognitive functions, minimising neurological impairment. Further analyses are needed to validate our data.
Objective: Navigated Transcranial Magnetic Stimulation (nTMS) has been little used to study Visuo-spatial (VS) circuits so far. Our work studies: I) VS functions in neurosurgical oncological patients by using repetitive nTMS (rnTMS); II) the possible subcortical circuits underneath. III) the correspondence between nTMS and Direct Cortical Stimulation (DCS) during awake procedures. Methods: We designed a monocentric prospective study, adopting a protocol to use rnTMS for preoperative planning, including VS functions for lesions potentially involving the VS network, including neurosurgical awake and asleep procedures. nTMS-based-DTI tractography allowed visualization of subcortical circuits. Statistical analyses on n TMS/DCS points were performed. Clinical results were collected pre- and postoperatively. Results: Finally, 27 patients with primitive intra-axial brain lesions were enrolled between April 2023-March 2024. Specific tests and an experimental integrated VS test (VISA) were used. The clinical evaluation (at 5±7, 30±10, 90±10 days after surgery) documented 33% of patients with ne-glect in the left hemisphere four days after surgery, and during 3-months-follow-up preservation of visuospatial function/clinical recovery [90.62% in MMSE, 98.86% in Bell Test, 80% in Clock test, 98% in OCS test]. The surgical strategy was modulated according to nTMS map. Subcortical bun-dles were traced to identify those most involved in these functions: SFLII>SLFII>SLFI. Comparison of nTMS and DCS points in awake surgery (n=10 patients) documented: Sensitivity (Se)=12%, Specificity (Sp)=91.21%, Positive Predictive Value (PPV)=42%, Negative Predictive Value (NPV)=66%. Accuracy ~63.7%. Conclusions: Based on our preliminary results, nTMS is advantageous to study cognitive func-tions, minimising neurological impairment. Further analyses are needed to validate our data.
Continuous infusions of MS and other opiates are widely used in the NICU as analgesics/sedatives for postsurgical pain and in neonates on mechanical ventilation. The study was designed to determine whether newborn piglets could be utilized for pharmacokinetic studies of continuous infusion MS. For this purpose, 6 spontaneously breathing conscious newborn piglets were administered a bolus of 100 μg/kg MS over 5 minutes, followed by a continuous infusion of MS at 100 μg/kg/hr for 4 hrs. Blood samples from the femoral artery and sagittal sinus vein were collected at 30 minutes post-bolus, at 1, 2, 3, & 4 hrs of infusion, and at 1 & 2 hrs post infusion for determination of plasma morphine levels by high pressure liquid chromatography. Pharmacokinetic parameters were estimated by area under the curve. Mean systemic plasma levels of morphine at 30 minutes post-bolus, at 4 hrs of infusion, and at 2 hrs post infusion were 151±45 ng/ml, 185±40 ng/ml, and 82±12 ng/ml, respectively. In the sagittal sinus vein, plasma MS levels were 133±44 ng/ml at 30 minutes post-bolus, 156±77 ng/ml at 4 hrs of infusion and 75±32 at 2 hrs post infusion. The mean clearance was 2.3 ml/kg/minute, mean volume of distribution was 2.0 L/kg, and mean elimination half-life was 8.3 hours. These data show that there was rapid equilibration of MS between the systemic and cerebrovascular circulation. The data further show that the pharmacokinetics of MS in the newborn piglet is comparable with previously reported data on human premature neonates. Therefore, we conclude that newborn piglets may be utilized as a valid animal model for further pharmacokinetic studies with MS and its effect on cerebral circulation.